Introducing Mi~Scan®
The new standard for breast tissue composition analysis
(Mi~Scan® is available for order, with shipments pending European regulatory approval)
Mi~Scan® uses safe, non-ionising radio waves to quickly measure and then analyse breast tissue properties.
The device does not require breast compression and can be used as frequently as required, in both diagnostic and primary care settings.
Know your breast density.
The ratio of fibro-glandular tissue to other tissues in your breast can significantly impact the ability of a standard Mammogram to detect cancer.
While the amount of fibro-glandular tissue typically reduces with age (particularly post-menopause), women of all ages can have “dense” breasts.
The good news is that other techniques are available that have higher sensitivity and specificity in “dense” breasts.
Density cannot be determined by the look or feel of a breast, and even interpretation from a Mammogram can be subjective.
The initial Mi~Scan® product quickly measures breast density, producing a density score that allows a woman to be referred for the most effective imaging technique for her tissue type first time.
Mi~Score will provide integration of Mi~Scan® breast density measurement with existing breast cancer risk profiling models to enable community based breast cancer risk assessment
Our ultimate goal is for the device to be used to assess breast cancer risk for all women, quickly, safely, comfortably, in a community setting and as frequently as required to detect more instances of breast cancer, earlier.
— Adrian Waller (Micrima CEO)